Zygogen is developing a cutting edge technology base for manipulation of the emerging model organism, zebrafish. Zebrafish has a demonstrated relevance to human disease and the potential to provide a more accessible, cost effective and high throughput alternative to the mouse, the industry standard for analysis and modeling of vertebrate development and pathology. Zygogen's technology platform enables the characterization of existing genes of unknown function, identification and validation of novel potential drug targets, development of relatively low cost vertebrate models of human disease and screening of drug candidates for therapeutic activity and toxicity
